Aquestive Therapeutics Receives FDA Approval for Exservan™ (rilu

249
AQST: Aquestive Therapeutics, Inc.
2019-11-25 08:00:10
Aquestive Therapeutics Receives FDA Approval for Exservan™ (riluzole) Oral Film

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.